- Home
- RPRX vs DOCS Comparison
RPRX vs DOCS Comparison
Compare RPRX & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- DOCS
- Stock Information
- Founded
- RPRX 1996
- DOCS 2010
- Country
- RPRX United States
- DOCS United States
- Employees
- RPRX N/A
- DOCS N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- DOCS Retail: Computer Software & Peripheral Equipment
- Sector
- RPRX Health Care
- DOCS Technology
- Exchange
- RPRX Nasdaq
- DOCS Nasdaq
- Market Cap
- RPRX 15.6B
- DOCS 13.7B
- IPO Year
- RPRX 2020
- DOCS 2021
- Fundamental
- Price
- RPRX $36.03
- DOCS $71.11
- Analyst Decision
- RPRX Strong Buy
- DOCS Buy
- Analyst Count
- RPRX 4
- DOCS 19
- Target Price
- RPRX $44.50
- DOCS $68.68
- AVG Volume (30 Days)
- RPRX 5.2M
- DOCS 1.4M
- Earning Date
- RPRX 11-05-2025
- DOCS 11-06-2025
- Dividend Yield
- RPRX 2.44%
- DOCS N/A
- EPS Growth
- RPRX 54.86
- DOCS 45.79
- EPS
- RPRX 2.32
- DOCS 1.17
- Revenue
- RPRX $2,305,243,000.00
- DOCS $589,636,000.00
- Revenue This Year
- RPRX $35.14
- DOCS $13.33
- Revenue Next Year
- RPRX $1.24
- DOCS $10.90
- P/E Ratio
- RPRX $15.51
- DOCS $60.92
- Revenue Growth
- RPRX 3.02
- DOCS 19.45
- 52 Week Low
- RPRX $24.05
- DOCS $40.87
- 52 Week High
- RPRX $38.00
- DOCS $85.21
- Technical
- Relative Strength Index (RSI)
- RPRX 51.05
- DOCS 49.49
- Support Level
- RPRX $35.36
- DOCS $69.16
- Resistance Level
- RPRX $36.67
- DOCS $74.33
- Average True Range (ATR)
- RPRX 0.74
- DOCS 2.20
- MACD
- RPRX 0.08
- DOCS -0.55
- Stochastic Oscillator
- RPRX 68.36
- DOCS 23.88
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.